News

Coronavirus (COVID-19) FDA Updates

The U.S. Food and Drug Administration today continued to take action in the ongoing response to the COVID-19 pandemic: MyStudies app is now available to investigators as a free platform to obtain informed consent securely from patients for eligible clinical trials.

Through the COVID MyStudies app, the investigator can send the informed consent document electronically to the patient or his or her legally authorized representative. Once the patient or representative has signed the form, he or she will receive an electronic copy. The investigator can then access the signed consent in a secure manner and print it or transfer the file electronically.

More info here

Share:
Summer brings sunlit days, long evenings, and countless opportunities to enjoy the outdoors. Yet for the pharmaceutical and...
[Sofia, Bulgaria] – Comac Medical is pleased to announce the publication of a new scientific article, co-authored by Professor...
Clinical trial supply management is a critical function in the execution of successful clinical trials. From forecasting and...